NEW YORK (PRWEB) February 15, 2023
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Massachusetts for 2023. Massachusetts is well-known as a leader in the healthcare technology space. Boston, in particular, has long been a hotbed of research and innovation in medical and life sciences, and the city is home to some of the top research institutes and hospitals in the world. Meanwhile, the high density of visiting patients and healthcare professionals make the state an ideal place for healthcare startups. This year’s awardees earned their places on our list thanks to their dedication to innovation and improving health outcomes for patients in the state and beyond across a variety of specialties, from genomics to immuno-oncology, medical robotics, and ocular therapeutics, among many others.
Some of the distinguished leaders on this year’s list include Meghan Scanlon, Senior Vice President and President, Urology for Boston Scientific, who is responsible for developing and bringing to market innovative, industry-leading solutions for urological, urogynecological, and gynecological diseases. Meanwhile, Jean-Paul Kress, CEO of MorphySys, has strategically repositioned the company from a leading antibody technology provider to a global, commercial-stage biopharmaceutical company with a strong late-stage pipeline. And Elizabeth Haines, Vice President of Regulatory & Clinical Affairs for Conformis, is responsible for developing and implementing strategies to maximize process efficiency and effectiveness, directing the global regulatory team's annual budgets, investments, and financial performance, and overseeing clinical operations.
This year’s awardees lead from a wide range of positions, from CEO and CTO to COO, President, and SVP. What they have in common is their commitment to revolutionizing the healthcare technology space, delivering innovations to improve the lives of clinicians and patients alike. Please join us in celebrating The Top 25 Healthcare Technology Leaders of Massachusetts for 2023.
Sadik Kassim (Danaher Corporation), Mark Cobbold (AstraZeneca), Meghan Scanlon (Boston Scientific), Eric Chenelle (Rapid Micro BioSystems), Paul Gudonis (Myomo), Jean-Paul Kress (MorphoSys), Gabriele Brambilla (Alira Health), Elizabeth Haines (Conformis), Jonathan Go (iCAD), Sanjiv Patel (Relay Therapeutics), Natan Linder (Tulip), Andrey Zarur (Greenlight Biosciences Inc.), Gilmore O’Neill (Editas Medicine), Paul Bolno (Wave Life Sciences), Antony Mattessich (Ocular Therapeutix, Inc.), Abba Protopapas (Mersana Therapeutics), Martha Rook (insitro), Lisa Wyman (Generate Biomedicines, Inc.), Sam Tran (Gritstone bio), Andrew Ashe (Verve Therapeutics), Yaron Rachmany (Variantyx), Andrew Miller (Karuna Therapeutics), Slava Akmaev (Scipher Medicine), Peter Olagunju (TCR² Therapeutics Inc.), Marc Blaustein (Finch Therapeutics Group).
The full article can be read at https://thehealthcaretechnologyreport.com/
About The Healthcare Technology Report
The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.